EBITDA (2021)
75,5 (20,4% of turnover)
Our financial data in facts & figures
EBIT (2021)
53,8 (14,5% of turnover)
NET RESULT (2021)
36,4 (9,8% of turnover)
RELATED PAPERS
OUR FIGURES BY FOCUS AREA (€ Millions, 2021)
Net revenue
371,2
€ Millions
OUR FIGURES BY PRODUCT CATEGORY (€ millions, 2021)
PRESCRIPTION DRUGS: 33%*
MEDICAL DEVICES: 43%*
VACCINES: 5%*
OTHER: 19%*
*percentage referring to Fidia Farmaceutici S.p.A.
OUR FIGURES BY GEOGRAPHICAL AREA (€ millions, 2021)
Net revenue
371,2
€ Millions
OUR GROUP
You are about to leave Fidia Pharma Egypt for Marketing Laboratories Services and Pharmacological Tests
All information you are about to see is related to a specific selected market, including the products’ portfolio, and therefore comply to different local regulations.
PROCEED
